Skip to main content
Top Header menu
About us
ALB D&I
Advertisement
Contact Us
Log in
search
Asia
China
India
Admin
Main navigation
News
Breaking News
Appointments
Deals
In House News
Other News
Features and Analysis
News By Jurisdiction
Expert commentary
Rankings
E-Magazines
E-Magazine Archive
Events
In-House Summits
Law Awards
Masterclasses
Partner Events
Forums & Conferences
Find A Firm
Legal Jobs
Virtual Events
Videos
Handbooks
ALB HONG KONG IPO HANDBOOK 2020
ALB ASIA INSOLVENCY & RESTRUCTURING HANDBOOK 2020
ALB LEGAL GUIDE TO THE GREATER BAY AREA 2021
ALB GUIDE TO SHANGHAI STAR MARKET IPOs 2021
Subscribe
Menu
News
Rankings
E-Magazines
Events
Find A Firm
Legal Jobs
Virtual Events
videos
handbooks
subscribe
盛德助力康方生物签署50亿美元合作许可协议(ZH/EN)
BY Charlie Wu 吴卓言 |
13 Dec 22
近日,总部位于中国的生物制药上市公司康方生物与 总部位于美国加利福尼亚的生物制药上市公司Summit Therapeutics Inc. 签署了一项交易总金额有望高达50亿美元合作许可协议。盛德律师事务所为康方生物提供了全程的法律服务。